Frizzled-9 activators are a class of small molecules and compounds that interact with the Frizzled-9 receptor, a key component of the Frizzled family of proteins. These activators are involved in the regulation of various signaling pathways, particularly the Wnt signaling pathway, which plays a fundamental role in the development and maintenance of various tissues in multicellular organisms. Frizzled-9, as one of the key members of the Frizzled receptor family, is primarily known for its role in transducing signals from Wnt ligands. Wnt signaling pathways are highly conserved and are crucial for processes such as cell proliferation, differentiation, and tissue patterning during embryonic development.
Frizzled-9 activators are designed to specifically bind to the Frizzled-9 receptor, thereby triggering or enhancing the downstream signaling cascade. These molecules can modulate the activity of the Frizzled-9 receptor by inducing conformational changes or promoting receptor dimerization, which, in turn, affects the initiation of intracellular signaling events. While the exact mechanisms of action of Frizzled-9 activators can vary, they share the common characteristic of facilitating Wnt signaling by promoting the activation of Frizzled-9. Understanding the structural and biochemical aspects of these activators is of paramount importance in deciphering the intricacies of Wnt signaling, as well as in exploring their potential applications in a variety of biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Activates Wnt signaling by inhibiting GSK-3β, indirectly enhancing the activity of Frizzled-9 through the stabilization of β-catenin. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
A small molecule activator that directly inhibits GSK-3β, resulting in the activation of Wnt signaling, which can activate Frizzled-9. | ||||||
WAY 262611 | sc-397019 sc-397019A | 5 mg 25 mg | $131.00 $520.00 | 2 | ||
Inhibits DKK-1, an antagonist of Wnt signaling, indirectly enhancing Wnt signaling and potentially activating Frizzled-9 activity. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Inhibits tankyrases, which indirectly activates Wnt signaling by stabilizing Axin, a component of the Wnt pathway, possibly activating Frizzled-9 activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Enhances Wnt signaling indirectly through the activation of cAMP production and PKA, which can potentially activate the activity of Frizzled-9. | ||||||
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Activates Wnt signaling by promoting β-catenin accumulation, potentially activating the activity of Frizzled-9. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Suggested as an inhibitor of Wnt signaling, which may indirectly influence the function of Frizzled-9 and other Frizzled receptors. | ||||||
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
A compound with potential to modulate Wnt signaling, although the exact mechanism is not fully elucidated, it may indirectly activate the activity of Frizzled-9. | ||||||